NeuroTrauma Sciences, LLC
2 clinical trials · Sponsor
◉ Watch NeuroTrauma Sciences, LLC
| Record | Firm | Date |
|---|---|---|
| A Phase 2a Study to Evaluate the Dose-response, Safety, Tolerability, Efficacy, and Population Pharmacokinetics of Intravenous NTS-521 Infusions in the Early Recovery Treatment From Acute Ischemic Stroke (NCT07742098) | NeuroTrauma Sciences, LLC | 2026-10-31 |
| Single Ascending Dose Safety and Tolerability of NTS-104 Healthy Adults (NCT05547438) | NeuroTrauma Sciences, LLC | 2023-05-01 |
Track NeuroTrauma Sciences, LLC automatically
Every clearance here is in the API, with alerts when new ones post.